Illness after measles-mumps-rubella vaccination

Area of Science:

• Pediatric infectious diseases
• Vaccinology
• Public health

Background:

• Measles-mumps-rubella (MMR) vaccination is a critical public health intervention.
• Understanding potential post-vaccine sequelae is important for parental counseling and vaccine policy.
• Previous studies have investigated MMR vaccine side effects, but comparisons of different administration ages are valuable.

Purpose of the Study:

• To document common sequelae following measles-mumps-rubella (MMR) vaccination.
• To compare post-vaccine symptoms in children receiving the MMR vaccine at 13 months versus 15 months of age.

Main Methods:

• A prospective cluster randomized controlled trial was conducted across 22 family practices.
• 253 infants completed the study, with half receiving the MMR vaccine at 13 months and the other half at 15 months.
• Outcomes included physician-assessed physical findings, maternal diaries of illnesses, and medical record reviews for hospital admissions.

Main Results:

• Increased rates of lymphadenopathy (23.8%), fever (16.8%), and rash (26.9%) were observed in the weeks following MMR vaccination.
• Fewer health problems were reported in the weeks after vaccination compared to the pre-vaccination period.
• No significant difference in adverse events or hospital admissions was found between the 13-month and 15-month vaccination groups.

Conclusions:

• Parents should be informed about potential transient side effects of MMR vaccination, including lymphadenopathy, nasal discharge, and rash.
• The timing of MMR vaccination (13 vs. 15 months) does not appear to significantly influence the occurrence of common sequelae.
• These findings support current vaccination schedules and aid in informed parental decision-making regarding MMR vaccine administration.